OCGN - Ocugen, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
1.71 -0.06 (-3.5%)	---	0.0 (0.0%)	-0.01 (-0.6%)	-0.07 (-4.09%)	0.01 (0.61%)	-0.01 (-0.6%)	-0.01 (-0.6%)

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Market Period: Closed

Earnings & Ratios

Basic EPS:
Diluted EPS:
Basic P/E:
Diluted P/E:
RSI(14) 1m:: 100.0
VWAP:: 1.65
RVol:: 0.4411

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	1.67 +0.02 (+1.21%)	Oct 15 09:30
1m	Price increase 1m	1.69 +0.02 (+1.2%)	Oct 15 05:15
1m	Price decrease 1m	1.65 -0.04 (-2.37%)	Oct 15 05:13
1m	Price increase 1m	1.72 +0.03 (+1.78%)	Oct 15 04:47
10m	Price decrease 10m	1.61 -0.06 (-3.59%)	Oct 14 19:28